Filing excerpt
The increase from the prior year quarter is primarily due to the February 2026 acquisition of OneOncology and increased pharmaceutical sales.
Source: Autobound Signal API · 68 signals tracked for Cencora · updated
Get Cencora's live signals in Claude or ChatGPT, or by API
What changed at Cencora this week? Use Autobound signals for cencora.com.Cencora completed the acquisition of OneOncology in February 2026, which drove operating expense increases and gross profit growth in U.S. Healthcare Solutions.
Filing excerpt
The increase from the prior year quarter is primarily due to the February 2026 acquisition of OneOncology and increased pharmaceutical sales.
What this signalsIntegration work after a deal often opens needs for new systems and services.
Regions named
sec-10qacquisitionCompletedGet every 10-Q signal for Cencora and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Cencora this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/c110f343-a9cd-4a1d-bdb2-d7fa6ea651fd returns this record as JSON. POST /v1/companies/enrich returns every signal for cencora.com.
{
"signal_id": "c110f343-a9cd-4a1d-bdb2-d7fa6ea651fd",
"signal_type": "sec-10q",
"signal_subtype": "acquisitionCompleted",
"detected_at": "2026-11-09T06:32:58.817+00:00",
"company": {
"name": "Cencora",
"domain": "cencora.com"
},
"data": {
"detail": "Cencora completed the acquisition of OneOncology in February 2026, which drove operating expense increases and gross profit growth in U.S. Healthcare Solutions. Integration and post-merger technology consolidation may create new vendor opportunities.",
"metrics": {
"timeframe": "current_year"
},
"quarter": "Q3",
"summary": "Acquisition of OneOncology closed in February 2026, driving significant gross profit and expense growth",
"excerpts": "The increase from the prior year quarter is primarily due to the February 2026 acquisition of OneOncology and increased pharmaceutical sales.",
"relevance": 0.85,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1140859/000114085926000034/cor-20260630.htm",
"filing_date": "2026-08-05",
"filing_year": 2026,
"fiscal_year": 2026,
"fiscal_year_end": "06/30",
"period_end_date": "2026-06-30",
"sales_relevance": "Active integration needs",
"signal_category": "strategic",
"regions_mentioned": [
"U.S."
]
}
}
curl https://signals.autobound.ai/v1/signals/c110f343-a9cd-4a1d-bdb2-d7fa6ea651fd \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"cencora.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.